Acrivon Therapeutics, Inc. (ACRV)
1.60
-0.03
(-1.84%)
USD |
NASDAQ |
May 29, 16:00
1.615
+0.02
(+0.94%)
Pre-Market: 20:00
Acrivon Therapeutics Total Liabilities (Quarterly) : 12.32M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Anika Therapeutics, Inc. | 45.49M |
| Savara, Inc. | 45.61M |
| Vericel Corp. | 129.40M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 107.83M |
| Shareholders Equity (Quarterly) | 95.52M |
| Debt to Equity Ratio | 0.0253 |
| Current Ratio | 8.976 |
| Net Debt Paydown Yield | 0.46% |